10
Participants
Start Date
November 4, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
ADX-629
125 mg twice daily for 28 days
ADX-629
250 mg twice daily for 28 days
RECRUITING
Bon Secours Liver Institute of Newport News, Richmond
RECRUITING
Florida Health Sciences Center/Tampa General Hospital/USF, Tampa
RECRUITING
Synergry Healthcare, Bradenton
RECRUITING
The Liver Institute at Methodist Dallas Medical Center, Dallas
RECRUITING
UDL Clinical Research, LLC, Houston
RECRUITING
Methodist Specialty and Transplant Hospital, San Antonio
Lead Sponsor
Aldeyra Therapeutics, Inc.
INDUSTRY